心房纤颤抗凝治疗出血风险评估的研究进展(1)
[摘要] 心房颤动是已被证实的缺血性脑卒中的独立危险因素。口服抗凝药物治疗能显著减少栓塞事件的发生,但抗凝治疗存在一定的出血风险,尤其是致命性大出血。因此,对房颤抗凝治疗患者的出血风险评估尤为重要。该文拟对房颤患者抗凝治疗的出血风险评估方法进行综述,为合理的临床决策提供一定的指导。[关键词] 心房颤动;抗凝;出血评分
[中图分类号] R541.7+5 [文献标识码] A [文章编号] 1674-0742(2019)03(c)-0192-03
[Abstract] Atrial fibrillation (AF) has been identified as an independent risk factor for ischemic stroke. Oral anticoagulants substantially reduce the risk of thromboembolic events, but with an inherent increased bleeding risk. And major bleeding may be devastating for AF patients. Therefore ......
您现在查看是摘要页,全文长 3980 字符。